Tezepelumab COPD Exacerbation Study

Clinical trial NCT04039113 · COMPLETED

Trial details

NCT number: NCT04039113
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2019-07-30
Primary completion: 2023-11-10
Enrollment: 337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.